pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    Jankistomig
    Solid Tumor Ottimo Pharma Ltd
  • Phase 3
    JointStem
    Osteoarthritis Biostar Stem Cell Research Institute
  • Phase 3
    Jynneos
    Jynneos
    Smallpox Bavarian Nordic AS
  • Preclinical
← prev
page 113 of 271
next →
Pain89
Neurology1
K-130
Neurogenic Orthostatic Hypotension (nOH)
$AMRX Amneal Pharmaceuticals, Inc.
  • Phase 3
    K-161
    Keratoconjunctivitis Sicca (Dry Eye) Kowa Co Ltd
  • Phase 1
    KA-34
    Osteoarthritis California Institute for Biomedical Research
  • KADCYLA
    KADCYLA (ADO-TRASTUZUMAB EMTANSINE)
    no indication Genentech Inc
  • KALYDECO
    KALYDECO (IVACAFTOR)
    1 INDICATIONS AND USAGE KALYDECO is indicated for the tre…$VERX Vertex, Inc.
  • KANJINTI
    KANJINTI (TRASTUZUMAB-ANNS)
    no indication$AMGN AMGEN INC
  • Phase 1
    KB-407
    Cystic Fibrosis$KRYS Krystal Biotech, Inc.
  • Phase 1
    KB-408
    Alpha-1 Antitrypsin Deficiency (A1AD)$KRYS Krystal Biotech, Inc.
  • Phase 2
    KB-707
    Metastatic Melanoma$KRYS Krystal Biotech, Inc.
  • Phase 2
    KB-801
    Neurotrophic Keratitis$KRYS Krystal Biotech, Inc.
  • Phase 2
    KBLP-001
    Plaque Psoriasis (Psoriasis Vulgaris) KoBioLabs Inc
  • Phase 1
    KBLP-002
    Asthma KoBioLabs Inc
  • Preclinical
    KBX-114
    Gynecological Cancer Kaida BioPharma Inc
  • Phase 1
    KER-0193
    Fragile X Syndrome Kaerus Bioscience Ltd
  • Preclinical
    KET-003
    ketamine [INN]
    Amyotrophic Lateral Sclerosis PharmaTher Holdings Ltd
  • Preclinical
    KET-101
    ketamine [INN]
    Pain PharmaTher Holdings Ltd
  • Phase 2
    KETAMINE HYDROCHLORIDE
    KETAMINE HYDROCHLORIDE
    Major Depressive Disorder Seelos Therapeutics, Inc.
  • Phase 3
    KETOROLAC TROMETHAMINE
    KETOROLAC TROMETHAMINE
    Post-Operative Pain Neumentum Inc
  • KEYTRUDA
    KEYTRUDA (PEMBROLIZUMAB)
    no indication Merck Sharp & Dohme LLC
  • KEYTRUDA QLEX
    KEYTRUDA QLEX (PEMBROLIZUMAB)
    no indication Merck Sharp & Dohme LLC
  • Preclinical
    KFPH-013
    Unspecified Cancer Jiangsu Carephar Pharmaceutical Co Ltd
  • Preclinical
    KFPH-015
    Influenzavirus A Infections Jiangsu Carephar Pharmaceutical Co Ltd
  • Preclinical
    KFPH-020
    Hypercholesterolemia Jiangsu Carephar Pharmaceutical Co Ltd
  • Phase 1
    KGX-101
    Solid Tumor Shanghai KangaBio Co Ltd
  • Preclinical
    KIN-102
    Solid Tumor Kinimmune Inc
  • Phase 1
    KINE-101A
    Rheumatoid Arthritis Kine Sciences
  • KISQALI FEMARA CO-PACK
    KISQALI FEMARA CO-PACK (LETROZOLE AND RIBOCICLIB)
    no indication NOVARTIS